Skip to content
Search

Latest Stories

India's single day Covid-19 tally nears 10,000

INDIA saw a record single-day jump of 9,851 Covid-19 cases and 273 deaths on Friday (5), pushing the nationwide infection tally to 2,26,770 and the death toll to 6,348, according to the health ministry.

India stood seventh among the nations worst hit by the Covid-19 pandemic after the US, Brazil, Russia, the UK, Spain and Italy.         The number of active Covid-19 cases stood at 1,10,960 while 1,09,461 people have recovered and one patient has migrated, the ministry said. The total confirmed cases includes foreigners.


Of the 273 deaths reported since Thursday (4) morning, 123 were in Maharashtra, 44 in Delhi, 33 in Gujarat, 16 in Uttar Pradesh, 12 in Tamil Nadu, 10 in West Bengal, six each in Telangana and Madhya Pradesh, four each in Karnataka, Bihar and Rajasthan, three each in Andhra Pradesh and Kerala, two in Uttarakhand and one each in Jammu and Kashmir, Haryana and Jharkhand.

Of the total 6,348 fatalities, Maharashtra tops tally with 2,710 deaths followed by Gujarat with 1,155 deaths, Delhi with 650, Madhya Pradesh with 377, West Bengal with 355, Uttar Pradesh with 245, Tamil Nadu with 220,  Rajasthan with 213,, Telangana with 105 and Andhra Pradesh with 71 deaths.

The death toll reached 57 in Karnataka and 47 in Punjab. Jammu and Kashmir has reported 35 fatalities due to the disease, Bihar has 29, Haryana has 24 deaths, Kerala has 14, Uttarakhand has 10, Odisha has seven and Jharkhand has reported six deaths so far.

Himachal Pradesh and Chandigarh have registered five Covid-19 fatalities each, Assam has recorded four deaths while Chhattisgarh has reported two deaths so far.   Meghalaya and Ladakh have reported one Covid-19 fatality each, according to the ministry data.

The highest number of confirmed cases in the country are from Maharashtra at 77,793, followed by Tamil Nadu at 27, 256, Delhi at 25,004, Gujarat at 18,584, Rajasthan at 9,862, Uttar Pradesh at 9,237 and Madhya Pradesh at 8,762.

The number of Covid-19 cases has gone up to 6,876 in West Bengal, 4,493 in Bihar, 4,320 in Karnataka and 4,223 in Andhra Pradesh.       It has risen to 3,281 in Haryana, 3,147 in Telangana, 3,142 in Jammu and Kashmir and 2,478 in Odisha.

Punjab has reported 2,415 coronavirus cases so far while Assam has 1,988 cases. A total of 1,588 people have been infected with the virus in Kerala and 1,153 in Uttarakhand.  Jharkhand has registered 793 cases, Chhattisgarh has 756, Tripura has 644, Himachal Pradesh has 383, Chandigarh has 301 cases, Manipur has 124, Goa has 166 and Ladakh has 90 cases.

Puducherry has 82 Covid-19 cases, Nagaland has 80, Arunachal Pradesh has 42 while Andaman and Nicobar Islands and Meghalaya have registered 33 infections each. Mizoram has reported 17 cases, Dadar and Nagar Haveli has 12 cases while Sikkim has reported two cases till now.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less